View Section: Financials
Natural Biocon Statements
54
Natural Biocon Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2023-09-30
%
35.12
100
32.136
94.5
2.984
5.5
—
0
0.32
0
1.058
1.2
1.926
4.3
—
0
—
0
1.926
4.3
—
0
1.926
4.3
0.169
11.373
2023-03-31
%
8.109
100
5.59
56.8
2.519
43.2
—
0
0.098
1.1
0.448
9.2
2.071
34
-0.002
-0.05
—
0
2.069
33.9
0.679
12.1
1.39
21.9
0.115
11.883
2022-09-30
%
4.434
100
3.199
84.9
1.235
15.1
—
0
0.355
1
0.824
9.5
0.411
5.6
-0.01
-0.2
—
0
0.401
5.4
—
0
0.401
5.4
0.035
11.373
2022-03-31
%
2.927
100
2.231
83.5
0.697
16.5
—
0
0.131
3.9
0.456
12.2
0.24
4.3
-0.006
-0.2
—
0
0.235
4
0.22
9.1
0.015
-5.1
0.001
11.373
2021-09-30
%
1.891
100
0.644
19.5
1.247
80.5
—
0
0.123
5.9
0.599
41.1
0.648
39.5
-0.002
0
-0.002
0
0.644
39.5
—
0
0.644
39.5
0.057
11.373
View Section: Balance Sheet